Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
EXAS Exact Sciences Corporation daily Stock Chart
EXAS [NASD]
Exact Sciences Corporation
Healthcare | Diagnostics & Research | USA
statements
Index- P/E- EPS (ttm)-1.04 Insider Own0.80% Shs Outstand149.73M Perf Week0.70%
Market Cap15.98B Forward P/E- EPS next Y-1.32 Insider Trans-14.13% Shs Float148.63M Perf Month38.30%
Income-154.40M PEG- EPS next Q-0.52 Inst Own91.80% Short Float9.19% Perf Quarter7.62%
Sales1.13B P/S14.13 EPS this Y55.40% Inst Trans0.35% Short Ratio7.93 Perf Half Y40.03%
Book/sh16.77 P/B6.39 EPS next Y41.60% ROA-4.30% Target Price118.67 Perf Year11.06%
Cash/sh8.20 P/C13.07 EPS next 5Y- ROE-7.60% 52W Range35.25 - 110.74 Perf YTD15.85%
Dividend- P/FCF- EPS past 5Y12.50% ROI-1.90% 52W High-6.96% Beta1.93
Dividend %- Quick Ratio6.40 Sales past 5Y244.80% Gross Margin75.10% 52W Low192.27% ATR4.43
Employees4110 Current Ratio6.80 Sales Q/Q34.50% Oper. Margin-24.20% RSI (14)58.35 Volatility3.94% 5.62%
OptionableYes Debt/Eq0.62 EPS Q/Q-93.40% Profit Margin-13.60% Rel Volume0.56 Prev Close107.14
ShortableYes LT Debt/Eq0.62 EarningsOct 29 AMC Payout- Avg Volume1.72M Price103.03
Recom1.30 SMA202.05% SMA5017.67% SMA20022.80% Volume952,946 Change-3.84%
Oct-08-20Resumed BTIG Research Buy $140
Apr-02-20Initiated Evercore ISI Outperform $70
Jan-10-20Resumed BTIG Research Buy $127
Jan-07-20Initiated Citigroup Buy $120
Dec-13-19Initiated Dougherty & Company Buy $120
Nov-15-19Initiated Stifel Buy
Oct-17-19Reiterated BofA/Merrill Buy $130 → $135
Oct-01-19Resumed Craig Hallum Buy $127
Sep-26-19Initiated Oppenheimer Outperform $130
Feb-26-19Upgrade Goldman Neutral → Buy $85 → $120
Oct-09-18Initiated UBS Buy
Sep-05-18Resumed The Benchmark Company Hold
Aug-13-18Reiterated Canaccord Genuity Buy $62 → $65
Apr-03-18Upgrade BTIG Research Neutral → Buy
Jan-29-18Initiated Goldman Neutral $51
Jan-08-18Reiterated The Benchmark Company Buy $60 → $65
Nov-13-17Downgrade Robert W. Baird Outperform → Neutral $56
Nov-01-17Downgrade BTIG Research Buy → Neutral
Oct-31-17Reiterated The Benchmark Company Buy $50 → $60
Oct-03-17Reiterated Canaccord Genuity Buy $45 → $60
Oct-12-20 09:00AM  
Exact Sciences Introduces the Oncotype MAP Pan-Cancer Tissue Test to Help Guide Treatment for Patients with Advanced Cancer
PR Newswire
Oct-10-20 03:00PM  
Stocks That Would Have Made You Rich Today
GOBankingRates
Oct-09-20 06:00AM  
Exact Sciences schedules third quarter 2020 earnings call
PR Newswire
Oct-08-20 09:00AM  
Exact Sciences Stock Could Sprint Higher in the Weeks Ahead
TheStreet.com
Oct-07-20 06:11AM  
Exact Sciences and Pfizer Extend and Amend Cologuard® Promotion Agreement
PR Newswire
Oct-04-20 06:27AM  
Got $500? Here Are 2 Stocks That Could Soar
Motley Fool
Oct-01-20 02:22PM  
7 Diagnostic and Genomic Stocks Storming Into October
Zacks
Sep-29-20 07:27AM  
Is Exact Sciences a Good Healthcare Stock to Buy Now?
Motley Fool
Sep-28-20 08:53AM  
3 Healthcare Stocks That Jumped Higher Last Week
Motley Fool
Sep-25-20 09:22AM  
ROCE Insights For Exact Sciences
Benzinga
Sep-24-20 03:37PM  
Why Exact Sciences Stock Skyrocketed Today
Motley Fool +26.85%
02:47PM  
Exact Sciences Jumps as Company Presents at Cowen Event
TheStreet.com
02:35PM  
Exact Sciences Stock Surges on Cancer Blood-Test Results
Barrons.com
12:11PM  
Why Exact Sciences Stock Is Trading Higher Today
Benzinga
Sep-21-20 04:27PM  
Illumina Announces $8 Billion Acquisition Of Former Cancer-Testing Spinoff Grail
Investor's Business Daily -5.11%
11:25AM  
EXACT Sciences (EXAS) Has Fallen 28% in Last One Year, Underperforms Market
Insider Monkey
Sep-17-20 06:00AM  
Exact Sciences to participate in Cowen Liquid Biopsy Summit
PR Newswire
Sep-07-20 12:52PM  
Hedge Funds Never Been This Bullish On EXACT Sciences Corporation (EXAS)
Insider Monkey
Sep-01-20 04:05PM  
Exact Sciences to participate in September investor conference
PR Newswire
Aug-29-20 11:31AM  
Why Is Exact Sciences (EXAS) Down 25.3% Since Last Earnings Report?
Zacks
Aug-01-20 04:03AM  
Exact Sciences (EXAS) Q2 2020 Earnings Call Transcript
Motley Fool
Jul-31-20 12:13PM  
Exact Sciences' (EXAS) Q2 Earnings Beat, Margin Declines
Zacks
11:13AM  
Why Exact Sciences pivoted into COVID-19 testing
Yahoo Finance Video
06:38AM  
Exact Sciences Beats Q2 Estimates Despite a COVID-19 Drag
Motley Fool
Jul-30-20 06:30PM  
Exact Sciences (EXAS) Reports Q2 Loss, Tops Revenue Estimates
Zacks
Jul-29-20 08:40AM  
Should You Buy Exact Sciences (EXAS) Ahead of Earnings?
Zacks
Jul-23-20 12:32PM  
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Should You Buy?
Zacks
11:30AM  
Has Exact Sciences (EXAS) Outpaced Other Medical Stocks This Year?
Zacks
Jul-17-20 08:00AM  
How Genetic Testing For Cancer Could Create A $51 Billion U.S. Market
Investor's Business Daily
Jul-12-20 12:00PM  
Did Hedge Funds Make The Right Call On XACT Sciences Corporation (EXAS) ?
Insider Monkey
Jul-08-20 07:45AM  
An Intrinsic Calculation For Exact Sciences Corporation (NASDAQ:EXAS) Suggests It's 46% Undervalued
Simply Wall St. +6.21%
06:00AM  
Exact Sciences schedules annual meeting, second quarter 2020 earnings call
PR Newswire
Jun-16-20 03:09PM  
Robinhood traders could learn from this growth-stock investor whos beaten indexes by a wide margin for years
MarketWatch
08:00AM  
Oncotype DX Genomic Prostate Score® Result Shows for the First Time the Value of the Test to Guide Treatment Plans for Unfavorable Intermediate-Risk Prostate Cancer Patients
PR Newswire
Jun-05-20 11:31AM  
Why Is Exact Sciences (EXAS) Up 2.4% Since Last Earnings Report?
Zacks
Jun-03-20 09:49AM  
Edited Transcript of EXAS earnings conference call or presentation 6-May-20 9:00pm GMT
Thomson Reuters StreetEvents
01:15AM  
Hedge Funds Cashing Out Of EXACT Sciences Corporation (EXAS)
Insider Monkey
May-29-20 08:00AM  
Exact Sciences Showcases Continued Progress in Cancer Diagnostics at ASCO 2020
PR Newswire
May-26-20 06:00AM  
Exact Sciences to participate in June investor conferences
PR Newswire
May-17-20 06:46AM  
Could Exact Sciences Be a Millionaire-Maker Stock?
Motley Fool
May-12-20 03:10PM  
Pivoting From Poop: How Exact Sciences is Turning to Option #2
Yahoo Finance Video
10:23AM  
Is Exact Sciences Stock a Buy?
Motley Fool
May-11-20 10:19AM  
Should Investors Buy the Dip in EXACT Sciences (EXAS) Stock?
Insider Monkey
May-07-20 11:30AM  
Exact Sciences Corp (EXAS) Q1 2020 Earnings Call Transcript
Motley Fool +6.35%
10:09AM  
Exact Sciences' (EXAS) Q1 Earnings Fall Y/Y, Margin Expands
Zacks
May-06-20 08:05PM  
Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates
Zacks
03:00PM  
EXACT Sciences Corp. to Host Earnings Call
ACCESSWIRE
May-05-20 10:30AM  
New Model Shared at Digestive Disease Week (DDW) Demonstrates the Value of Cologuard® When Using Real-World Adherence Rates for Comparing Colorectal Cancer Screening Methods
PR Newswire
10:16AM  
Should You Buy Exact Sciences (EXAS) Ahead of Earnings?
Zacks
10:06AM  
Varian (VAR) Earnings and Revenues Surpass Estimates in Q2
Zacks
08:45AM  
Buy 5 Top Stocks Set to Beat Earnings Estimates Tomorrow
Zacks
May-04-20 06:00AM  
Exact Sciences to participate in May investor conference
PR Newswire
May-03-20 07:36AM  
2 Cheap Healthcare Stocks to Buy Now
Motley Fool
Apr-30-20 10:49AM  
Surmodics (SRDX) Q2 Earnings and Revenues Beat Estimates
Zacks
Apr-29-20 12:34PM  
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks
Apr-22-20 05:20AM  
Exact Sciences Reports 63% Reduction For Cologuard Testing in April
SmarterAnalyst
Apr-08-20 05:51PM  
Why 'Kimtirement' is a real thing with this longtime biotech exec
American City Business Journals +6.02%
06:00AM  
Exact Sciences schedules first-quarter 2020 earnings call
PR Newswire
Apr-02-20 09:00AM  
10x Genomics Appoints Kim Popovits to Board of Directors
GlobeNewswire
06:00AM  
Exact Sciences Highlights The Opportunity To Seek Screening With Cologuard® Through Telehealth
PR Newswire
Mar-26-20 05:45PM  
Exact Sciences (EXAS) Stock Sinks As Market Gains: What You Should Know
Zacks
01:50PM  
Epic, Exact Sciences among Wisconsin tech firms responding to COVID-19
American City Business Journals
Mar-24-20 09:44AM  
Exact Sciences Grows on New Deals, Down on Coronavirus Scare
Zacks +16.11%
Mar-21-20 09:22AM  
Is Exact Sciences Corporation's (NASDAQ:EXAS) CEO Pay Fair?
Simply Wall St.
Mar-19-20 06:00AM  
Exact Sciences Takes Action during COVID-19 Pandemic
PR Newswire +32.48%
Mar-17-20 05:45PM  
Exact Sciences (EXAS) Gains But Lags Market: What You Should Know
Zacks
03:18PM  
Hedge Funds Have Never Been This Bullish On EXACT Sciences Corporation (EXAS)
Insider Monkey
Mar-12-20 11:30AM  
Exact Sciences (EXAS) Down 39.7% Since Last Earnings Report: Can It Rebound?
Zacks -10.91%
Mar-04-20 07:37AM  
The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies
Benzinga
Feb-27-20 08:42AM  
Genetic Test Gets Okayed by FDA: 4 Stocks to Keep an Eye On
Zacks
Feb-25-20 08:28AM  
The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement
Benzinga -9.44%
Feb-24-20 10:39PM  
Exact Sciences Announces Upsizing and Pricing of 0.3750% Convertible Senior Notes Due 2028
PR Newswire
04:01PM  
Exact Sciences Announces Offering of $850 Million Convertible Senior Notes Due 2028
PR Newswire
Feb-19-20 05:44AM  
Bull of the Day: Guardant Health (GH)
Zacks
Feb-17-20 05:24AM  
Edited Transcript of EXAS earnings conference call or presentation 11-Feb-20 10:00pm GMT
Thomson Reuters StreetEvents
Feb-12-20 03:52PM  
Exact Sciences to acquire more biotech companies; plans to launch liver cancer test in 2020
American City Business Journals
09:18AM  
The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data
Benzinga
08:56AM  
Exact Sciences (EXAS) Q4 Earnings and Revenues Rise Y/Y
Zacks
Feb-11-20 06:15PM  
Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates
Zacks
05:07PM  
Exact Sciences beats income, revenue projections in 4Q earnings report
American City Business Journals
04:05PM  
Exact Sciences Announces Fourth-Quarter 2019 Results
PR Newswire
07:23AM  
The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology
Benzinga
Feb-04-20 06:41PM  
Should Growth Investors Buy this Cancer Screening Biotech Stock?
Zacks
12:30PM  
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks
11:44AM  
What's in the Cards for Exact Sciences' (EXAS) Q4 Earnings?
Zacks
Feb-03-20 05:45PM  
Exact Sciences (EXAS) Outpaces Stock Market Gains: What You Should Know
Zacks
04:05PM  
Eaton Vance Worldwide Health Sciences Fund Buys 3 Stocks in 4th Quarter
GuruFocus.com
01:01PM  
Exact Sciences doubled capital investment, job creation goal in Wisconsin, per report
American City Business Journals
Jan-27-20 05:50PM  
Exact Sciences (EXAS) Dips More Than Broader Markets: What You Should Know
Zacks
06:00AM  
Exact Sciences schedules fourth-quarter, full-year 2019 earnings call
PR Newswire
Jan-24-20 11:24AM  
Exact Sciences, GameStop, Intel, Intuitive Surgical and Skyworks highlighted as Zacks Bull and Bear of the Day
Zacks
09:55AM  
What's in Store for IDEXX Laboratories' (IDXX) Q4 Earnings?
Zacks
09:06AM  
Can Critical Care Aid Edwards Lifesciences (EW) Q4 Earnings?
Zacks
05:20AM  
Bull of the Day: Exact Sciences (EXAS)
Zacks
Jan-23-20 01:30PM  
Exact Sciences' stock jumps after analysts question competitor's product
American City Business Journals
10:45AM  
Will New Buyouts Aid Quest Diagnostics (DGX) Q4 Earnings?
Zacks
09:17AM  
Will Segmental Growth Aid Hologic (HOLX) in Q1 Earnings?
Zacks
08:23AM  
What's in Store for Align Technology's (ALGN) Q4 Earnings?
Zacks
Jan-22-20 07:30AM  
Exact Sciences Gains After Rival's Colorectal Cancer Screening Product Falls Short
TheStreet.com +10.55%
Jan-21-20 06:31AM  
Is Exact Sciences Corporation (NASDAQ:EXAS) Trading At A 40% Discount?
Simply Wall St.
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; and Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer. The company's pipeline products focuses on the research and development of enhancing Cologuard's performance characteristics, and blood or other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; Biocartis N.V.; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Conroy Kevin TPresident and CEOOct 01Sale103.5527,4252,839,829920,914Oct 02 05:54 PM
Hoof TorstenGeneral Manager, InternationalSep 24Option Exercise41.534,401182,7746,418Sep 28 04:33 PM
Hoof TorstenGeneral Manager, InternationalSep 24Sale80.004,401352,0802,017Sep 28 04:33 PM
Conroy Kevin TPresident and CEOSep 01Sale75.0319,9271,495,123948,339Sep 02 04:32 PM
Hoof TorstenGeneral Manager, InternationalAug 19Option Exercise43.401,51665,7949,981Aug 21 04:31 PM
Hoof TorstenGeneral Manager, InternationalAug 19Sale84.907,964676,1442,017Aug 21 04:31 PM
Hoof TorstenGeneral Manager, InternationalAug 17Option Exercise0.002,55108,465Aug 19 04:15 PM
Conroy Kevin TPresident and CEOAug 03Sale93.8025,1982,363,560968,266Aug 04 05:18 PM
Carey Thomas D.DirectorJul 31Option Exercise9.2415,620144,32952,492Aug 04 05:21 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 31Option Exercise21.686,638143,91275,861Aug 04 05:02 PM
Zanotti Katherine SDirectorJul 31Option Exercise8.5221,029179,16762,936Aug 04 04:54 PM
LEVANGIE DANIEL JDirectorJul 31Option Exercise9.309,86591,69924,881Aug 04 04:58 PM
Carey Thomas D.DirectorJul 31Sale94.0030,6202,878,28021,872Aug 04 05:21 PM
Zanotti Katherine SDirectorJul 31Sale94.0021,0291,976,72641,907Aug 04 04:54 PM
Doyle James EdwardDirectorJul 31Sale94.002,539238,66632,459Aug 04 04:45 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 31Sale93.8337,5003,518,77138,361Aug 04 05:02 PM
LEVANGIE DANIEL JDirectorJul 31Sale94.009,865927,31015,016Aug 04 04:58 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 29Sale95.588,746835,94369,223Jul 30 08:18 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 28Option Exercise94.8118,7501,777,68877,969Jul 30 08:18 PM
Zanotti Katherine SDirectorJul 28Sale96.131,164111,89541,907Jul 30 06:49 PM
Stenhouse MarkPresident, CologuardApr 03Sale56.6911,948677,33229,571Apr 06 04:41 PM
Stenhouse MarkPresident, CologuardApr 02Option Exercise0.0025,000041,519Apr 06 04:41 PM
Doyle James EdwardDirectorFeb 28Sale77.542,000155,08032,440Mar 03 07:20 PM
Conroy Kevin TPresident and CEOFeb 28Sale80.179,750781,658992,963Mar 02 07:13 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 28Sale80.172,383191,04558,578Mar 02 07:15 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 27Option Exercise0.005,025061,141Mar 02 07:15 PM
Conroy Kevin TPresident and CEOFeb 27Option Exercise0.0020,57501,002,713Mar 02 07:13 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 27Sale80.271,627130,59956,116Feb 28 04:37 PM
Stenhouse MarkPresident, CologuardFeb 27Sale80.271,05184,36416,519Feb 28 04:39 PM
Conroy Kevin TPresident and CEOFeb 27Sale80.2713,8751,113,746982,138Feb 28 04:36 PM
Conroy Kevin TPresident and CEOFeb 26Option Exercise0.0029,3370996,013Feb 28 04:36 PM
Stenhouse MarkPresident, CologuardFeb 26Option Exercise0.003,262017,570Feb 28 04:39 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 26Option Exercise0.003,436057,743Feb 28 04:37 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 25Sale85.114,910417,89054,307Feb 26 05:13 PM
Conroy Kevin TPresident and CEOFeb 25Sale85.1118,1151,541,768966,676Feb 26 05:11 PM
Conroy Kevin TPresident and CEOFeb 24Option Exercise0.0034,3250984,791Feb 26 05:11 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 24Option Exercise0.009,300059,217Feb 26 05:13 PM
Cole G BradleyGeneral Manager - DiagnosticsFeb 19Option Exercise35.7717,356620,77637,550Feb 21 04:58 PM
Cole G BradleyGeneral Manager - DiagnosticsFeb 19Sale100.0027,3562,735,60010,194Feb 21 04:58 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 19Sale100.681,153116,0842,495Feb 20 05:55 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 18Option Exercise0.003,64803,648Feb 20 05:55 PM
Hoof TorstenGeneral Manager, InternationalFeb 15Option Exercise0.002,09105,914Mar 27 04:15 PM
Cole G BradleyGeneral Manager - DiagnosticsJan 16Sale90.3010,000903,0008,653Jan 17 04:50 PM
Conroy Kevin TPresident and CEODec 16Option Exercise17.4811,440199,992950,466Dec 18 05:19 PM
Cole G BradleyGeneral Manager - DiagnosticsNov 21Sale80.3828,0162,251,92630,987Nov 25 05:18 PM
open in yahoo | open in reuters | open in google